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Abstract
The effective and sustained delivery of DNA locally would increase the applicability of gene
therapy in tissue regeneration and therapeutic angiogenesis. One promising approach is to use
porous hydrogel scaffolds to encapsulate and deliver nucleotides in the form of nanoparticles to
the affected sites. We have designed and characterized micro-porous (µ-pore) hyaluronic acid
hydrogels which allow for effective cell seeding in vitro post scaffold fabrication and allow for
cell spreading and proliferation without requiring high levels of degradation. These factors,
coupled with high loading efficiency of DNA polyplexes using a previously developed caged
nanoparticle encapsulation (CnE) technique, then allowed for long-term sustained transfection and
transgene expression of incorporated mMSCs. In this study, we examined the effect of pore size
on gene transfer efficiency and the kinetics of transgene expression. For all investigated pore sizes
(30, 60, and 100 µm), encapsulated DNA polyplexes were released steadily starting by day 4 for
up to 10 days. Likewise, transgene expression was sustained over this period, although significant
differences between different pore sizes were not observed. Cell viability was also shown to
remain high over time, even in the presence of high concentrations of DNA polyplexes. The
knowledge acquired through this in vitro model can be utilized to design and better predict
scaffold-mediated gene delivery for local gene therapy in an in vivo model where host cells
infiltrate the scaffold over time.
Keywords
Porous hydrogel; Controlled release; Non-viral gene delivery; Enzymatically degradable; Cell
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1. Introduction
Vascularization of tissue engineering constructs remains the primary reason for construct
failure in vivo [1]. Without the rapid infiltration of blood vessels, diffusion alone is
insufficient to sustain migrating endogenous or exogenously implanted cells far from the
construct surface. Researchers have recently been focusing on macroscopic biomaterial
design to help promote branching from existing blood vessels into the biomaterial. Micro-
scale interconnected pores produced through salt-leaching [2, 3], gas foaming [4–6],
lyophilization [7–10], and sphere templating [11–14] have shown to be effective in allowing
for cellular infiltration and, subsequent, enhanced scaffold vascularization.
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In addition to the structural characteristics of the scaffold, the effective local delivery of
angiogenic factors, including VEGF and PDGF, are necessary to promote blood vessel
formation. For tissue regeneration, localized gene delivery can promote the expression of
tissue inductive factors to guide tissue formation. Local gene delivery via hydrogel scaffolds
has been studied for nearly a decade primarily through the encapsulation of naked DNA
during hydrogel formation [5, 15–19]. Although naked DNA achieves gene expression and
guided regeneration in vivo [5, 15], limitations with low gene transfer efficiency and rapid
diffusion of the DNA from the hydrogel scaffold motivated the use of DNA nanoparticles
instead of naked DNA. DNA condensed either with cationic peptides, lipids, or polymers
has previously been introduced into fibrin hydrogels [13, 20–22], enzymatically degradable
poly(ethylene glycol) (PEG) hydrogels [23, 24] and PEG-hyaluronic acid hydrogels [25].
Poly(ethylene imine) (PEI) is a widely utilized cationic polymer for non-viral gene delivery;
it is able to condense DNA through electrostatic interactions between the positively charged
amines on the PEI and the negatively charged phosphates on the DNA, forming
nanoparticles (polyplexes) in the range of 50 to 200 nm [26]. PEI has been successfully used
in vivo to deliver DNA or siRNA to the brain [27, 28], lungs [29–32], abdomen [33], and
tumors [34–36].
Hydrogel properties, such as the type of natural or synthetic polymer used, can likewise be
an important factor in the promotion of vascularization. While a synthetic polymer, such as
PEG, can be biochemically inert, natural polymers, such as hyaluronic acid (HA), possess
intrinsic qualities which can play a role in signaling to surrounding cells. HA, an anionic,
non-sulfated glycosaminoglycan and major component of the ECM, is widely distributed in
connective, epithelial and neural tissue [37]. HA has recently gained popularity as a
biomaterial for tissue engineering and regeneration due to its high biocompatibility and low
immunogenicity [38–41]. Moreover, degraded fragments of HA or HA oligomers are known
to promote angiogenesis and upregulate MMP expression [42–44]. As a result, several
studies have demonstrated that HA-based hydrogels are good candidates for culturing stem
cells [45–48]. HA specifically interacts with cell surface receptors, such as CD44, RHAMM
(receptor for HA mediated motility) and ICAM-1 (intercellular adhesion molecule 1), and
contributes to tissue hydrodynamics, cell proliferation and migration [49, 50]. Semi-
synthetic hyaluronic acid (HA) hydrogels which are also degradable by matrix
metalloproteinases (MMPs) have previously been developed for culturing mouse
mesenchymal stem cells in three-dimensions [51, 52]. MMPs are normally expressed during
tissue remodeling and are up-regulated during wound healing, microenvironment
remodeling, and in diseased states and can, therefore, serve as triggers for bioactive signal
delivery. While peptides and growth factors can be easily incorporated within these
hydrogels, rapid degradation by proteases generally limits their effectiveness in long-term
cell culture. MMP-degradable hyaluronic acid hydrogels have previously been used to
encapsulate DNA/poly(PEI) polyplexes as a means of non-viral gene delivery to stem cells
[53]. We found that as the matrix degraded through cell-secreted proteases, the cells were
transfected with the polyplexes encountered during their migration. However, direct
encapsulation of the polyplexes resulted in aggregation when the concentration exceeded 0.2
µg/µl. Aggregation of polyplexes can result in increased toxicity and inconsistent
transfection of encapsulated or infiltrating cells. To overcome this concentration limitation
we previously developed a caged nanoparticle encapsulation process (CnE) to incorporate
DNA polyplexes inside a variety of hydrogel scaffolds without particle aggregation [54, 55].
This approach utilizes neutral saccharides (sucrose) and polysaccharides (agarose) to protect
the polyplexes from inactivation and aggregation during lyophilization and hydrogel
formation, respectively.
In this paper, we investigate gene transfer to mouse mesenchymal stem cells (mMSCs)
seeded within porous hyaluronic acid hydrogel scaffolds. Porosity in hydrogels has
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previously been shown to promote cell migration in vitro [9, 56, 57], as well as hydrogel
integration and vascularization in vivo [2, 12]. In addition, these porous constructs may
serve as non-viral gene carriers by either coating the porous hydrogels or embedding
bioactive signals directly within the gel, allowing for cellular uptake [4, 5, 13]. Porous fibrin
hydrogels loaded with DNA polyplexes were able to deliver genes to attached fibroblasts
[13], however, polyplexes aggregated and elicited cellular toxicity. In the work presented
here, the CnE technique was employed to load higher amounts of polyplexes without
inducing aggregation. To optimize cell seeding into porous hydrogels in vitro, we propose a
two-phase hydrogel system that contains polyplexes in a stiff (3.5%) µ-pore HA-MMP gel
and mMSCs in a softer (2.5%) n-pore HA-MMP hydrogel within the µ-sized pores. As the
inner gel is degraded quickly in the presence of cell-secreted proteases, it will allow for cell
spreading and proliferation, while the polyplexes in the stiff µ-pore backbone will have a
more gradual and sustained release upon hydrogel degradation. For in vitro studies,
transfection was quantified using a Gaussia luciferase reporter plasmid. Studies were
focused on how pore size influenced the efficiency of gene transfer and the kinetics of
transgene expression. These factors are important for designing successful scaffolds to
mediate gene delivery in vivo. The goal is to transfect either: (i) encapsulated stem cells in a
DNA- or siRNA-loaded hydrogel scaffold in vitro or (ii) cells infiltrating an acellular
scaffold containing DNA or siRNA in vivo.
2. Materials and Methods
2.1 Materials
Peptides Ac-GCRDGPQGIWGQDRCG-NH2 (HS-MMP-SH) and Ac-GCGYGRGDSPG-
NH2 (RGD) were purchased from Genscript (Piscataway, NJ). Sodium hyaluronan (HA)
was a gift from Genzyme Corporation (60 kDa, Cambridge, MA). Linear poly(ethylene
imine) (PEI, 25kDa) was purchased from Polysciences (Warrington, PA). Vectors
expressing mammalian secreted Gaussia Luciferase (pGluc) were obtained from New
England Biolabs (Ipswich, MA) and expanded using a Giga Prep kit from Qiagen following
the manufacturer’s protocol. All other chemicals were purchased from Fisher Scientific
(Pittsburgh, PA) unless otherwise noted.
2.2 Hyaluronic acid modification
Sodium hyaluronan was modified to contain acrylate functionalities as previously described.
Briefly, hyaluronic acid (2.0 g, 5.28 mmole, 60 kDa) was reacted with 18.0 g (105.5 mmole)
adipic dihydrazide (ADH) at pH 4.75 in the presence of 4.0 g (20 mmole) 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC) overnight and purified through
dialysis (8000 MWCO) in DI water for 2 days. The purified intermediate (HA-ADH) was
lyophilized and stored at − 20°C until used. Approximately 56% of the carboxyl groups
were modified with ADH, which was determined using 1H-NMR (D2O) by taking the ratio
of peaks at δ = 1.6 and 2.3 corresponding to the 8 hydrogens of the methylene groups on the
ADH to the singlet peak of the acetyl methyl protons in HA (δ = 1.88). HA-ADH (1.9 g)
was reacted with N-Acryloxysuccinimide (NHS-Ac) (1.33 g, 4.4 mmole) in HEPES buffer
(10mM HEPES, 150mM NaCl, 10mM EDTA, pH 7.2) overnight and purified through
dialysis in DI water for 2 days before lyophilization. The degree of acrylation was
determined to be ~10% using 1H-NMR (D2O) by taking the ratio of the multiplet peak at δ
= 6.2 corresponding to the cis and trans acrylate hydrogens to the singlet peak of the acetyl
methyl protons in HA (δ = 1.88).
2.3 Polyplex lyophilization
For CnE, plasmid DNA (100–250 µg) and L-PEI (91.3–228.3 µg) were mixed in 3.5 mL
water in the presence of 35 mg (0.10 mmole) of sucrose (Ultra pure, MP Biomedicals, Santa
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Ana, CA) and incubated at room temperature for 15 min. Low-melting point agarose (1.0
mg, UltraPureTM Agarose, Tm = 34.5–37.5°C, Invitrogen, Grand Islands, NY) in 1.5 mL
water was added before lyophilization. Each aliquot was intended for a 100 µL hydrogel.
For smaller hydrogel volumes, the sucrose concentration remained unchanged (relative to
DNA levels) while the agarose concentration was proportionally decreased.
2.4 Design template using PMMA microspheres
Microsphere templates for porous hydrogels were prepared as previously described [58].
Briefly, PMMA microspheres (27–33, 53–63, and 90–106 µm, Cospheric, Santa Barbara,
CA) were bought dry. Approximately 12–14 mg of microspheres were then added into
glass-bottom silicon wells (6 mm × 1 mm, D × H) and covered with a glass slide. The
microspheres were then packed by slight tapping for 1–2 min and examined for even
packing through phase microscopy. The glass-bottom silicon wells were then placed into an
oven and the microspheres were sintered for 22 hr at 150°C.
2.5 Porous (and nano-porous) HA hydrogel formation
Hydrogels were formed by Michael-type addition of acrylate-functionalized HA (HA-Ac)
with bis-cysteine containing MMP peptide crosslinkers at pH 7.6–7.8. Prior to reaction, a
hydrogel precursor solution was made by mixing HA-Ac with a lyophilized aliquot of cell
adhesion peptide, RGD, for 30 min at 37°C. After incubation, HA-RGD was mixed with the
remaining HA-Ac and PBS pH 7.4 for a final gel concentration of 3.5 w/v% HA and 500
µM RGD. Finally lyophilized aliquots of the crosslinker (0.91 mg HS-MMP-SH) were
diluted in 18.2 µL of PBS buffer pH 7.4 immediately before addition to a mixture of
lyophilized (CnE) or fresh (direct encapsulation) DNA/PEI polyplexes and the hydrogel
precursor solution. For direct encapsulation, DNA and PEI were mixed to form
nanoparticles through vortexing for 15 s and incubating for 15 min at RT before being
mixed with the HA solution and crosslinkers to form hydrogels. For porous hydrogels, 20 µl
of gel solution was then added directly on top of a PMMA microsphere template, covered
with a glass slide, and perfused into the template by centrifugation at 1500 rpm for 6 min at
4°C. The slide was then incubated at 37°C for 30–45 min to induce polymerization. Once
complete, the gels were removed from the silicon wells and placed directly into 100%
acetone for 48 hr to dissolve the PMMA microsphere template. The acetone solution was
replaced 2–3× during this incubation. The gels were then serially hydrated into sterile PBS
and left in PBS until ready for use. For nano-porous hydrogels, the gel solution was
sandwiched between two Sigmacoted slides using 1mm thick plastic spacers and incubated
at 37°C for 30–45 min to induce polymerization. Once complete, the gels were placed
directly into sterile PBS and left in PBS until ready for use.
2.6 Subcutaneous implant model
All in vivo studies were conducted in compliance with the NIH Guide for Care and Use of
Laboratory Animals and UCLA ARC standards. 6 to 8-week old male Balb/c mice each 20–
30 grams were used to study cellular infiltration and blood vessel formation in HA
hydrogels since this strain and size has been previously used for wound healing and
angiogenesis assays [59, 60]. Nanoporous or single-phase porous hydrogels were made
exactly as described above with sucrose and agarose (but without DNA polyplexes) and cut
to 6 mm in diameter using a biopsy punch, for final overall dimensions of 6 mm × 1 mm, D
× H. All porous hydrogels were made using 100 µm beads. In fabricating the hydrogels, the
starting reagents were sterilized through filtering with a 0.22µm filter. After scaffold
fabrication, the hydrogels were washed with sterile PBS and kept in PBS with 1% P/S.
Immediately prior to surgery, mice were anesthetized with 4–5% isoflurane through a nose
cone inhaler. After anesthesia induction, the isoflurane concentration was lowered to 1.5–
2.5% for the remainder of the surgery. The back of the mouse was subsequently shaved and
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washed with Betadine and 70% ethanol. Two incisions appropriate to the size of the implant
were made in the skin aside the midline of the animal using scissors. Two subcutaneous
pockets were subsequently created by blunt dissection using rounded-end scissors. Within
the created pockets, the implants were inserted. After insertion of the hydrogels, each
incision was subsequently closed with a single wound clip. All animals were observed daily
for signs of inflammation and pain and also administered carprofen injections for the first 48
hrs post survival surgery. After 1, 2, and 3 weeks, mice were sacrificed with CO2 overdose.
Two 1 cm2 pieces of tissue were collected from each mouse containing the implant and the
surrounding tissue and skin, fixed in 4% PFA overnight at 4°C, dehydrated in 70% EtOH,
and finally paraffin embedded. A total of 12 mice were used in this study, with 6 mice per
hydrogel condition. Two animals were sacrificed per condition at each time point.
2.7 Immunohistochemisty and Immunofluorescence
Paraffin embedded sections were deparaffinized by incubation in multiple xylene washes
followed by serial hydration from 100% ethanol into 100% water. Cell membranes were
permeabilized with a 15 min incubation at 37°C in .1 mg/ml proteinase K solution. Sections
were then washed with PBS and incubated in blocking buffer (1% goat serum (Jackson
Immuno Research Labs, West Grove, PA) + .05% Tween-20 in PBS) for 1 hr at RT before
being incubated in primary antibody solution (1:100 dilution in blocking buffer of rat anti-
mouse CD31 (BD Pharmingen, San Diego, CA)) overnight at 4°C. Sections were again
washed with PBS and incubated in blocking buffer for 10 min at RT before being incubated
for 2 hrs at RT in secondary antibody solution (1:200 dilution in blocking buffer of goat
anti-rat Alexa 568 (Invitrogen, Grand Islands, NY) which also contained α-smooth muscle
actin-FITC (1:500 dilution, Sigma-Aldrich, St. Louis, MO) and DAPI nuclear stain (1:500
dilution, Invitrogen). Sections were then washed twice in PBS, mounted and imaged using
an inverted Zeiss fluorescence microscope.
2.8 Gel preparation for SEM imaging
Each porous hydrogel was serially dehydrated in 25% increments of water/EtOH for 10 min
at a time. Hydrogels were left in 100% EtOH overnight after which they were placed in a
dry holder, air dried and, finally, placed under vacuum until time for imaging. The gels were
then coated with a thin layer of gold using a gold sputterer and imaged using a JEOL
JSM-6700F FE-SEM in the UCLA MCTP core facility. For SEM images in Figure 1, a
Nova 230 Nano SEM in low vacuum mode was used. Hydrogels were slightly dried and
imaged directly without further dehydration or metal coating.
2.9 Preparation and characterization of two-phase gel
Porous hydrogels were prepared exactly as described above, with final overall dimensions of
~8 mm × 1 mm, D × H, after swelling in PBS. After the initial porous gel was formed it was
stained with FITC using a 10× dilution in PBS of a 1mg/ml stock in DMSO. The gel was
incubated at RT for 30 min in the dark, followed by several washes in PBS until the wash
solution was no longer changing color. Prior to formation of the second phase, some HA had
been modified with Alexa-350 using NHS-Alexa350 (Invitrogen, Grand Islands, NY). NHS-
Alexa350 was added at a 1:5 ratio of HA:NHS. The solution was allowed to react for 2 hrs
with mixing in the dark, after which it was dialyzed and lyophilized. To form the second
phase, 15 µl per 20 µl porous gel of 2.5% HA-Alexa350 was mixed with MMP crosslinker
and immediately added on top of the 3.5% HA porous gel. Due to the fluid nature of the
2.5% HA gel solution prior to gelation, it was able to infiltrate evenly into the pores and
form a soft gel after incubation at 37°C for at least 30 min. The two phases were then
visualized using fluorescence microscopy.
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2.10 Polyplex Visualization
To visualize the polyplex distribution, hydrated gels were stained with ethidium bromide (12
µM) for 1-hr before imaging with a fluorescent (Observer Z1 Zeiss) microscope. To better
visualize the distribution throughout the hydrogel, multiple z-stacks 1.9–2.3 µm thick were
taken for each image, deconvoluted to minimize background, and presented as maximum
intensity projections.
2.11 DNA Loading
In order to determine the extent of release of the encapsulated polyplexes, plasmid DNA was
radiolabeled with 3H-dCTP (100 µCi, MP Biomedicals, Santa Ana, CA) using a Nick
translation kit (Roche, Indianapolis, IN) as per the manufacturer’s protocol. Briefly, an
equimolar mixture of dATP, dGTP, dTTP, and 3H-dCTP was prepared and added to the
DNA (5 µg) solution. Once the enzyme solution was added to the mixture, the final solution
(200 µl) was gently mixed by pipetting and incubated for 2 hr at 15°C. The reaction was
stopped by addition of 10 µl 0.2 M EDTA (pH=8.0) and heating to 65°C for 10 min. The
DNA was purified using the mini Prep kit from Qiagen (Valencia, CA) following the
manufacturer’s instructions. The final DNA concentration was 0.2 µg/µl. In order to
determine the extent of release of the encapsulated polyplexes, gels were formed using the
protocols indicated above with 1% radiolabeled DNA. To determine the overall loading, all
of the acetone and hydrating washes were collected and analyzed for DNA content. Once
completely hydrated, the gels were incubated with 0.25% trypsin/EDTA to completely
degrade the gel in order to determine the total amount of DNA still encapsulated. DNA
concentrations were measured using a scintillation counter at the UCLA Chemistry core
facility. The readout was analyzed using a standard curve.
2.12 Cell culture
Mouse bone marrow derived mesenchymal stem cells (D1, CRL12424) were purchased
from ATCC (Manassas, VA) and cultured in DMEM (Invitrogen, Grand Islands, NY)
supplemented with 10% bovine growth serum (BGS, Hyclone, Logan, UT) and 1%
penicillin/streptomycin (Invitrogen) at 37°C and 5% CO2. The cells were passaged using
trypsin following standard cell culture protocols every 2–3 days.
2.13 Preparation of two-phase gels with mMSCs
Hydrogels were prepared exactly as described above with a final HA concentration of 2.5 w/
v%, 500 µM RGD, and 5000 cells/µl (final volume). For those two-phase gels that did not
contain cells, PBS pH 7.4 was used in place of the cell solution. Immediately after mixing
the precursor solution with crosslinker, 15 µl of the gel solution was pipetted directly on top
of a previously made 20 µl porous hydrogel (~8 mm × 1 mm, D × H, after swelling in PBS)
in a low-attachment 96-well plate for a total of 75,000 cells per gel. Due to the fluid nature
of the 2.5% gel solution, it was able to evenly distribute within the pores of porous hydrogel
before completely gelling. The gel was allowed to sit at RT for 2–3 min after which it was
incubated at 37°C for 30 min to induce polymerization. 100 µl complete DMEM was then
added to each well and replaced daily. All two-phase gels containing cells had µ-pore gels
with 1 µg/µl DNA.
2.14 Cell viability and spreading
Cell viability was studied with the LIVE/DEAD® viability/cytotoxicity kit (Molecular
Probes, Eugene, OR). Briefly, 1 µL of ethidium homodimer-1 and 0.25 µL of calcein AM
from the kit were diluted with 500 µL DMEM to make the staining solution. Each gel (2–3
gels per condition per time point) was stained with 150 µL of staining solution for 30 min at
37°C in the dark before imaging. To better analyze cell spreading, gels (2–3 gels per
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condition per time point) were fixed for 30 min at RT using 4% PFA, rinsed with PBS,
treated with .1% triton-X for 10 min and stained for 90 min in the dark with DAPI for cell
nuclei (500× dilution from 5 mg/ml stock, Invitrogen, Grand Islands, NY) and rhodamin-
phalloidin (5 µl per 200 µl final stain solution, Invitrogen) in 1% bovine serum albumin
solution. The samples were then washed with .05% tween-20. For both cell viability and cell
spreading, an inverted Observer Z1 Zeiss fluorescence microscope was used to visualize
samples. To better visualize the distribution throughout the hydrogel, multiple z-stacks 1.9–
2.3 µm thick were taken for each image, deconvoluted to minimize background, and
presented as maximum intensity projections.
2.15 Cell proliferation
MTT assay (CellTiter 96R AQueous One Solution Cell Proliferation Assay, Promega,
Madison, WI) was used to quantify the cell proliferation rate. 20 µl MTT reagent with 100 µl
DMEM was added to each gel in a 96-well plate and incubated at 37°C for 2 hr. The cells
were lysed after 2 hr with addition of 10% sodium dodecyl sulfate. The solutions were
transferred to a new plate and absorbance was measured at 490 nm using a standard plate
reader. Three gels for each condition were analyzed at each time point.
2.16 DNA release in the presence of mMSCs
In order to determine the extent of release of the encapsulated polyplexes, two-phase gels
were formed as indicated above with 1% radiolabeled DNA. Gels (n=3) were placed in 150
µl of release solution. At the indicated time points, 150 µl of the solution was removed and
an additional 150 µl of fresh release medium was added. Following the final release medium
collection, the gels were incubated with 0.25% trypsin/EDTA to result in complete release
of the DNA from the gel upon degradation. DNA concentrations were measured using a
scintillation counter at the UCLA Chemistry core facility. The readout was analyzed using a
standard curve and plotted as percent of total DNA encapsulated.
2.17 Gel degradation in the presence of mMSCs
Gel degradation was determined using a slight modification of a previously established
carbazole assay to quantify the uronic acid content in solution [61]. The same two-phase
samples used for the DNA release studies were also used to determine degradation. 5 µl of
release solution was diluted 20-fold using saturated benzoic acid and added to 600 µl of
chilled 25 mM sodium tetraborate in concentrated sulfuric acid. The sample was vortexed,
incubated at 100°C for 10 min, and brought back down to 4°C. Next, 20 µl of .125%
carbazole in absolute ethanol was added to each sample, vortexed, incubated at 100°C for 15
min, and finally brought back down to 4°C. Sample absorbance was determined at 530 nm
with a pure benzoic acid sample used as a blank. Concentration was then obtained in
reference to a D-glucuronolactone standard curve and finally plotted as % uronic acid
released based on the total amount of HA in both phases. Alternatively, pore size
measurements were made manually from phase images of gels with cells growing within the
pores over time. At each time point 3 gels were analyzed per condition, with 9
measurements per gel (3 measurements at 3 different z-planes). AxioVision software was
used to make measurements.
2.18 Gene transfer from two-phase hydrogels
pGluc/PEI nanoparticle loaded hydrogels with mMSCs were made as described above. Each
day the media was collected and frozen immediately at −20°C and fresh media was added to
each gel. To quantify secreted Gaussia luciferase levels in the media, the samples were
thawed on ice and assayed using a BioLux™ Gaussia Luciferase Assay Kit (New England
Biolabs, Ipswich, MA) as per the manufacturer’s protocol. Briefly, 20 µl sample was mixed
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with 50 µl 1× substrate solution, pipetted for 2–3 sec, and read for luminescence with a 5 sec
integration. Background was determined with media from gels that did not contain any DNA
and values were expressed as relative light units (RLU).
2.19 Gluc escape from hydrogels
Mouse MSCs were transfected for 24 hrs in tissue culture (TC) plastic and then detached
using trypsin/EDTA and either re-plated onto TC plastic or encapsulated within HA-MMP
degradable hydrogels at a density of 5000 cells/µl gel. The total number of cells was kept
constant. After 48 hrs, conditioned media was collected from all samples and Gaussia
luciferase expression was determined for both systems. Total Gaussia luciferase expression
in HA hydrogels was normalized to that on TC plastic.
2.20 Statistical Analysis
All statistical analysis was performed using Instat (GraphPad, San Diego, CA). Experiments
were statistically analyzed using the Tukey test to compare all pairs of columns using a 95%
confidence interval. Outliers in the gene transfer studies were detected using the Grubbs’
outlier test. All errors bars represent the standard error of the mean (SEM).
3. Results and Discussion
Acrylates were conjugated onto the HA backbone through a two-step process, as previously
described [53]. Briefly, HA was first modified with ADH by EDC coupling and the resulting
hydrazide group was then modified with NHS-acrylate to obtain acrylamide functionalities.
Analysis by NMR showed showed that ~10% of the carboxylic acids were modified with
acrylates, resulting in approximately 16 acrylates per HA chain. RGD adhesion peptides
were incorporated through Michael-type addition of the cysteine side chain in the peptide to
the acrylate groups on the HA backbone, followed by addition of an MMP-degradable
peptide crosslinker to form the final hydrogels. Porous hydrogels are formed around a
PMMA microsphere template which is finally dissolved away using acetone, leaving behind
a porous hydrogel structure. Scanning electron microscopy was used to examine the
structural differences between gels made with and without the bead template (Fig 1A–D).
Hydrogels made with lyophilized agarose and sucrose with the bead template had large,
interconnected pores that were uniformly distributed (µ-pore), while those made directly
without the template had no visible micro-sized pores (n-pore).
As a preliminary study to determine the potential for porous hydrogels to enhance cellular
infiltration in vivo, both µ-pore and n-pore hydrogels were implanted subcutaneously into
the back of Balb/c mice. Implants were excised each week for three weeks, paraffin-
embedded and sectioned along the height of the gel to include the attached muscle and skin.
Hematoxylin and eosin (H&E) stained sections showed micro-scale interconnected pores
allowed for enhanced cellular infiltration from the host into the biomaterial increasingly
with time (Fig 1E, F, I, J). By one week, cells were able to infiltrate into almost all visible µ-
pores without noticeable gel degradation. Conversely, n-pore gels had minimal cellular
infiltration along the periphery of the hydrogel even after three weeks (Fig 1G, H, K, L). At
sites where cells were present the hydrogel appeared to be degrading and large pores became
visible. Staining for PECAM positive endothelial cells showed thin vessel-like structures
within µ-pores at three weeks (Fig 1M, N), while no endothelial cells could be observed in
any of the n-pore implants at the same time point (Fig 1O, P). Thus, the presence of
emerging vasculature could be attributed to the pre-existing interconnected porous structure.
These results highlighted the potential for the use of porous hydrogels in vivo. We anticipate
that with the addition of pro-angiogenic growth factors through the delivery of non-viral
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vectors encoding for the factors, blood vessel formation within porous hydrogels could
further enhance vessel number, maturity, and rate of formation.
To optimize the design of porous hydrogels with encapsulated non-viral vectors, in vitro
studies were initially conducted. Lyophilized polyplexes were incorporated into the hydrogel
during hydrogel gelation (Fig 2A) to achieve a final DNA concentration of either 1 or 2.5 µg
DNA/µL hydrogel (20 or 50 µg DNA total per 20 µl gel, respectively). The distribution of
the polyplexes inside the hydrogel scaffold was determined by staining with ethidium
bromide post hydrogel formation. Polyplexes made using the CnE technique were observed
mostly as nonaggregated particles and uniformly distributed throughout the gel (Fig 2B, C).
In contrast, those made even at 1µg/µl without agarose and sucrose were highly aggregated
(Fig 2D). These results confirmed that the CnE technique for incorporating high amounts of
DNA into HA hydrogels was essential for nonaggregated distribution. Using radiolabeled
DNA, we were also able to verify that there was minimal loss of incorporated DNA during
gel formation, acetone washes, and initial swelling in PBS (Fig 2E).
In addition to the incorporation of non-viral DNA nanoparticles, pore size was also assessed
as a potential factor in determining gene transfer kinetics. PMMA beads of various sizes
(~30, 60, and 100 µm) were used to form the template. To visualize the porous structure and
specifically the differences in porous hydrogels made using the various sized microspheres,
hydrogels were dehydrated in ethanol and imaged using scanning electron microscopy (Fig.
2F–H). Due to the tight range in bead size, the pore size distribution in each hydrogel was
qualitatively uniform. However, exact pore size could not be measured from these SEM
images since ethanol dehydration resulted in a significant reduction in overall gel size to
~40% of the original size. Lastly, as a result of sintering the microspheres, interconnectivity
was present between almost every neighboring pore.
To easily seed cells within pores in vitro, we utilized a two-phase hydrogel technique. Once
µ-pore 3.5% HA hydrogels were formed, mouse MSCs were mixed into a thin 2.5% n-pore
HA-MMP hydrogel precursor solution and pipetted directly on top of the µ-pore hydrogel
(Fig 3A). Due to the fluid nature of the 2.5% hydrogel precursor solution initially at room
temperature, the gel solution was able to flow throughout the pores of the porous hydrogel
and distribute the cells within the pores. In this situation, the porous hydrogel was used as a
template upon which to seed cells in a softer gel phase. To ensure even distribution of the
second phase within the pores of the porous hydrogel, two-phase HA hydrogels were
prepared in the absence of cells. After the initial porous gel was formed it was stained with
FITC. HA modified with Alexa350 was then used to form the inner phase gel. The two
phases were then visualized using fluorescence microscopy. Both phases could clearly be
distinguished and were present in most parts of the gel system (Fig 3B–D).
The toxicity of the DNA/PEI polyplexes was assessed using the LIVE/DEAD assay. Since
the concentrations used in this study were in general high for in vitro culture systems, some
toxicity was expected. However, since most cells were not in direct contact with the
polyplexes embedded within the porous phase and were only exposed to the released
polyplexes and those near the pore surfaces, toxicity remained low throughout the culture
period (Fig 4A–F). With respect to the total number of cells, very few dead (i.e. red) cells
could be observed in all pore sizes. However, a number of cells could be seen exiting the
hydrogel from the bottom surface and binding to the tissue culture well, especially with
increasing pore size. Likewise these cells stained green (S.Fig 1), indicating low levels of
toxicity from released DNA polyplexes. Cell spreading as a function of pore size was also
investigated. Cell spreading was observed for all conditions even by 2 days as a result of the
soft 2.5% HA second phase the cells were seeded within (Fig 4G–L). Last, the metabolic
activity of the cells inside the DNA-loaded hydrogels was studied using the MTT assay. No
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significant changes in metabolic activity were observed within the hydrogel (Fig 4M–O). To
measure the metabolic activity of the cells solely within the hydrogels, we placed each gel
into a new well immediately prior to measuring. As a result, we cannot directly correlate
these findings to a decrease or halt in cell proliferation, but rather maintain that the number
of cells within each gel remained relatively constant over time.
The release of the entrapped polyplexes was assessed using radiolabeled DNA either in the
absence (i.e. PBS control) or presence of cells. Release studies indicated a sustained release
of polyplexes in the presence of cells over a 10 day period (Fig 5A), while less than 2% of
the polyplexes were released in PBS in all pore size hydrogels both due to the absence of
enzymes and potentially in part due to the electrostatic interactions of the positively charged
polyplexes with the negatively charged HA backbone. By day 10, polyplexes in 30 µm gels
had the greatest percentage of release compared to the 60 and 100 µm pore sizes, but
because of the increased variability among the 100 µm gels were only significantly greater
than the 60 µm gels (Fig 5B, p<.05). The sustained release of DNA polyplexes was a
significant improvement over the burst release of naked DNA from porous PEG gels, with
over 50% of DNA being released by day 3 [5] in PBS, yet comparable to the release of
DNA/PEI polyplexes from porous fibrin hydrogels [13].
The same release samples were also used to measure hydrogel degradation by measuring
uronic acid content in the release solution using a modified carbazole assay. For all pore
sizes, HA gel degradation was greater in the presence of cells compared to the PBS control,
although this difference was not significant for the 100 µm pore size (Fig 5C, D). However,
for all pore sizes some uronic acid release was observed even in PBS up until about 96 hrs
after which no further release was observed (Fig 5C). This directly corresponded to the time
at which polyplexes started to be released in the presence of cells. We believe that the
majority of the uronic acid released into solution until this point came from the 2.5% inner
phase gel, especially since the 2.5% gel is naturally very weak with a storage modulus of
only 130.00 ± 4.92 Pa (S.Fig 2). When used as a second-phase gel, it is likely that there was
incomplete crosslinking occurring, particularly in the case of smaller pores where you are
forcing macromolecular chains into a smaller, more tortuous space and thus the likelihood of
the reactive groups encountering one another decreases. After ~96 hrs, it is expected that a
larger contribution is made by degradation of the porous, outer phase since degradation is
required for polyplex release. Again, we observed that the amount of uronic acid released
was the greatest in the 30 µm gels with almost 80% being released. At this point the gels
became extremely soft, but were still held together by the remaining crosslinks. We
hypothesized that the second-phase was completely gone by this point and those cells still
remaining in the gel were then mostly in contact with the porous phase. As a secondary
approach to monitoring degradation over time, pore size measurements were made from
phase images of two-phase gels with cells at various time points (n=27). The porous, outer
structure could still be clearly distinguished even in the presence of the second phase and
showed that in only the 30 µm gels did the pore size significantly increase from ~30 to ~60
µm in diameter (Fig 5E, p<.005). Based on the degree of uronic acid release we expected to
see an increase in pore size as a result of degradation in the 60 µm gels and a smaller change
in the 100 µm gels; however, due to a large degree of error in the carbazole assay so there
was no clear discrepancy between the findings of the two separate experiments, as well as
those trends found between the DNA release and carbazole assays. Importantly, all the
results do indicate that with a 30 µm pore size, significantly more degradation occurs
(compared to larger pore size gels.) This difference may be a result of greater confinement
of encapsulated cells leading to an increased need for degradation to allow growth and
subsequently a greater polyplex release rate.
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Gene transfer was also assessed as a function of pore size and DNA concentration. Gaussia
luciferase (Gluc) reporter plasmid was incorporated into the various pore size hydrogels at a
concentration of 1 µg/µl hydrogel solution and transgene expression was quantified using a
Gaussia luciferase quantification assay. Histograms show kinetic data of all samples (n=8)
over time (Fig 6A–C). Cumulative data shows an increase in Gluc expression with time,
although by day 10 the differences between various pore size gels were not statistically
significant (Fig 6D). The lack of any trend between pore sizes is most likely a result of the
high variability between samples even within a single pore size, as demonstrated in the
histograms (Fig 6A–C). We hypothesize that the variability arises from the local distribution
of the cells within the pores with respect to the polyplexes in the first gel phase. Cells that
are closer to the pore surfaces or are able to infiltrate into the first gel phase are in direct
contact with polyplexes and are transfected at higher levels than those far from the pore
surfaces (Fig 6E). To alleviate this issue, cells could have been directly seeded onto pore
surfaces without the presence of the second gel phase. However, seeding cells in this manner
within HA based gels is very difficult because of the lack of immediate adhesion to the pore
surfaces even in the presence of 500 µm RGD. Cells then tended to flow through the pores
and fall out of the gel more easily, which is specifically why we utilized the two-phase cell
seeding technique. Finally, to ensure all expressed protein was being recovered for analysis
and not the cause of the transfection variability, cells were first transfected for 24 hrs in
tissue culture (TC) plastic and then detached using trypsin/EDTA and either re-plated onto
TC plastic or encapsulated within HA-MMP degradable hydrogels. After 48 hrs, Gaussia
luciferase expression was determined for both systems and showed similar levels of
expression indicating no significant sequestration of Gaussia luciferase within the hydrogel
(Fig 6F).
4. Conclusions
Porous HA-MMP hydrogels were used to encapsulate DNA/PEI polyplexes and transfect
seeded stem cells as they slowly degraded the matrix. Porous hydrogels allowed for
effective cell seeding in vitro post scaffold fabrication, and when coupled with high loading
efficiency of DNA polyplexes, allowed for long-term sustained transfection and transgene
expression of incorporated mMSCs in various pore size µ-pore hydrogels. For all
investigated pore sizes transgene expression was sustained for up to 10 days. Cell viability
was also shown to remain high over time, even in the presence of high concentrations of
DNA polyplexes. We believe the proposed hydrogel system has applications for controlled
release of various DNA particles and other gene delivery vectors for in vivo tissue
engineering and blood vessel formation. We anticipate that the presence of an open pore
structure will increase the rate of vascularization through enhanced cellular infiltration into
the gel and that the added delivery of DNA encoding for angiogenic growth factors will
result in long lasting angiogenic signals.
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Figure 1.
SEM was used to characterize gel structure of µ-pore hydrogels (A, B) made using the bead
template and n-pore hydrogels (C, D) made directly without the template. A, C = 200×, B, D
= 750× magnification images. Sections from a mouse subcutaneous implant model show
~100 µm diameter pores (E, F, I, J) allow for enhanced cellular infiltration from the host into
the HA hydrogels when compared to n-pore counterparts (G, H, K, L). Staining for
endothelial markers at 21 days indicated significant positive staining for µ-pore hydrogel
implants (M, N) and not for the n-pore implants (O, P). Red = PECAM positive staining =
endothelial cells, yellow appear to be erythrocytes, blue = cell nuclei, asterisks indicate
where the gel is present. E-H, M, O = 40×, I-L, N, P = 100× magnification images.
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Figure 2.
(A) Schematic of CnE process to incorporate nonaggregated DNA/PEI polyplexes into
porous hydrogels. (B–D) Using the CnE technique 1–2.5 µg/µl DNA could be incorporated
without significant aggregation, while direct incorporation of 1 µg/µl resulted in highly
aggregated particles; DNA was visualized via ethidium bromide staining. (E) 3H-dCTP
labeled DNA was used to verify over 95% of loaded DNA remained in the gel after porous
gel processing. Porous hydrogels were synthesized by using different sized PMMA template
beads. (F–H) SEM was used to characterize gel structure as a function of bead size. F–H =
500× magnification images.
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Figure 3.
(A) To effectively seed cells and allow for rapid cell spreading without significant gel
degradation, cells were seeded within the pores of a 3.5% µ-pore HA gel directly with a soft
2.5% HA gel. To visualize each phase separately the µ-pore phase was stained with FITC
(B) and the inner, n-pore phase was stained with Alexa-350 (C). (D) Merged fluorescence
image of a two-phase hydrogel made using 100 µm beads.
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Figure 4.
(A–F) Live/dead staining showed most cells were alive (live = green, dead = red) in all pore
size hydrogels after 2 and extending through 7 days. (G–L) Cells were also fixed with 4%
paraformaldehyde and stained with rhodamine-phalloidin (actin) and DAPI (cell nuclei) to
better visualize cell spreading. (M–O) MTT assay indicated similar cellular metabolism
between various pore sizes (n=3).
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Figure 5.
(A) 3H-dCTP radiolabeled DNA was incorporated into the hydrogels to study release
kinetics in the presence of mMSCs (Cell). PBS (P) was used as an acellular control. (B)
Cumulative release data at Day 10 shows 30 µm pore size gels had the largest percentage of
released DNA. (C, D) Two-phase hydrogel degradation was monitored using a carbazole
assay to directly quantify uronic acid in solution. Release of uronic acid after 92 hrs is
assumed to be primarily from the µ-pore phase. (E) Gel degradation was also assessed by
measuring pore size over time (n=27) using phase microscopy.
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Figure 6.
Gaussia luciferase reporter plasmid was incorporated into the various pore sized hydrogels
at 1 µg/µl hydrogel and transgene expression was quantified using a Gaussia luciferase
quantification assay. (A–C) Histograms show kinetic data of all samples (n=8) over time for
each pore size hydrogel. (D) Cumulative data shows an increase in Gluc expression with
time, although by day 10 the differences between gels types are not statistically significant.
(E) To verify all protein expressed was being accounted for, previously transfected cells
were placed into HA gels and assessed for Gluc expression after 48 hours and compared to
those cells on tissue culture (TC) plastic. The results were not significantly different.
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